+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Gene Delivery Technologies Market Share, Size, Trends, Industry Analysis Report, By Mode; By Application; By Method; By Regions; Segment Forecast, 2021 - 2028

  • PDF Icon

    Report

  • 127 Pages
  • April 2021
  • Region: Global
  • Polaris Market Research
  • ID: 5321999
The global gene delivery technologies market size is expected to reach USD 7.86 billion by 2028 according to this new study. The report “Gene Delivery Technologies Market Share, Size, Trends, Industry Analysis Report, By Mode (Biological [Adenovirus, Retrovirus, AAV, Lentivirus, Other Viruses, Non-viral], Chemical, Physical); By Application (Gene Therapy, Cell Therapy, Vaccines, Research); By Method; By Regions; Segment Forecast, 2021 -2028” gives a detailed insight into current market dynamics and provides analysis on future market growth.

In 2020, the gene therapy market segment accounted for the largest share. Worldwide acceptance of gene therapies and subsequent rise in clinical research activities have boosted the segment’s market growth. Moreover, rising approvals for gene therapy products and services also accelerated the gene delivery technologies market growth prospects.

The vaccine market segment is projected to witness a lucrative growth rate over the gene delivery technologies study period. This is primarily due to the ability of such vaccines for different treatment approaches for both preventive and therapeutic areas. They have the potential to activate potent humoral responses. This has boosted the demand for gene editing tools for vaccine development.

The gene delivery technologies market segment is anticipated to benefit from a sudden rise in COVID-19 cases. As of August 2020, more than 25 research groups have been working for vector-based vaccines to contain COVID-19 infection. Similarly, approximately 20 research teams are exploring approaches to develop nucleic acid vaccines.

Market participants in gene delivery technologies industry include Horizon Discovery Group Co., QIAGEN, Oxford Biomedica, SignaGen Laboratories, Hoffmann-La Roche AG, Vectalys, Sirion-Biotech GmbH, Takara Bio Inc, Bio-Rad Laboratories, Inc, Thermo Fisher Scientific, Inc, OriGene Technologies, Inc, System Biosciences, Promega Corporation, and Catalent Inc
The market players operating in the gene delivery technologies industry are focusing on mergers and acquisitions to stay competitive in the market. In line with this, in May 2020, Merck, completed the acquisition of Themis, an immune-modulation therapy to expand its vaccine development program for the surging COVID-19 numbers. Similarly, earlier, in May 2019, already acquired Brammer Bio, a U.S-based company engaged in the development of viral vectors to be used in gene therapies.

The publisher has segmented the gene delivery technologies market report on the basis of mode, application, method, and region:


Gene Delivery Technologies, Mode Outlook (Revenue-USD Million, 2016-2028)


  • Biological
  • Adenovirus
  • Retrovirus
  • AAV
  • Lentivirus
  • Other viruses
  • Non-viral
  • Chemical
  • Physical

Gene Delivery Technologies, Application Outlook (Revenue-USD Million, 2016-2028)


  • Gene Therapy
  • Cell Therapy
  • Vaccines
  • Research

Gene Delivery Technologies, Method Outlook (Revenue-USD Million, 2016-2028)


  • Ex vivo
  • In vivo
  • In vitro

Gene Delivery Technologies, by Regional Outlook (Revenue-USD Million, 2016-2028)


  • North America
  • U.S
  • Canada
  • Europe
  • France
  • Germany
  • UK
  • Italy
  • Spain
  • Netherlands
  • Austria
  • Asia Pacific
  • China
  • India
  • Japan
  • Malaysia
  • South Korea
  • Indonesia
  • Central & South America
  • Mexico
  • Brazil
  • Argentina
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
Frequently Asked Questions about the Gene Delivery Technologies Market

What is the estimated value of the Gene Delivery Technologies Market?

The Gene Delivery Technologies Market was estimated to be valued at $2.64 Billion in 2021.

What is the growth rate of the Gene Delivery Technologies Market?

The growth rate of the Gene Delivery Technologies Market is 16.9%, with an estimated value of $7.86 Billion by 2028.

What is the forecasted size of the Gene Delivery Technologies Market?

The Gene Delivery Technologies Market is estimated to be worth $7.86 Billion by 2028.

Who are the key companies in the Gene Delivery Technologies Market?

Key companies in the Gene Delivery Technologies Market include Horizon Discovery Group Co., QIAGEN, Oxford Biomedica, SignaGen Laboratories, Hoffmann, La Roche AG, Vectalys, Sirion and Takara Bio Inc..

Table of Contents

1. Introduction
1.1. Report Description
1.1.1. Objectives of the Study
1.1.2. Market Scope
1.1.3. Assumptions
1.2. Stakeholders
2. Executive Summary
2.1. Market Highlights
3. Research Methodology
3.1. Overview
3.1.1. Data Mining
3.2. Data Sources
3.2.1. Primary Sources
3.2.2. Secondary Sources
4. Gene Delivery Technologies Market Insights
4.1. Gene Delivery Technologies - Industry snapshot
4.2. Gene Delivery Technologies Market Dynamics
4.2.1. Drivers and Opportunities
4.2.1.1. Technogical advancements in delivery systems
4.2.1.2. Ageing population across the globe
4.2.2. Restraints and Challenges
4.2.2.1. Product recalls
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers (Moderate)
4.3.2. Threats of New Entrants: (Low)
4.3.3. Bargaining Power of Buyers (Moderate)
4.3.4. Threat of Substitute (Moderate)
4.3.5. Rivalry among existing firms (High)
4.4. PESTLE Analysis
4.5. Gene Delivery Technologies Market Industry trends
5. Gene Delivery Technologies Market Assessment by Mode
5.1. Key Findings
5.2. Introduction
5.2.1. Global Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
5.3. Biological
5.3.1. Global Gene Delivery Technologies Market, by Biological, by Region, 2016 - 2028 (USD Million)
5.3.2. Adenovirus
5.3.2.1. Global Adenovirus Gene Delivery Technologies Market, by Region, 2016 - 2028 (USD Million)
5.3.3. Retrovirus
5.3.3.1. Global Retrovirus Gene Delivery Technologies Market, by Region, 2016 - 2028 (USD Million)
5.3.4. AAV
5.3.4.1. Global AAV Gene Delivery Technologies Market, by Region, 2016 - 2028 (USD Million)
5.3.5. Lentivirus
5.3.5.1. Global Lentivirus Gene Delivery Technologies Market, by Region, 2016 - 2028 (USD Million)
5.3.6. Other Viruses
5.3.6.1. Global Other Viruses Gene Delivery Technologies Market, by Region, 2016 - 2028 (USD Million)
5.3.7. Non-viral
5.3.7.1. Global Non-viral Gene Delivery Technologies Market, by Region, 2016 - 2028 (USD Million)
5.4. Chemical
5.4.1. Global Gene Delivery Technologies Market, by Chemical, by Region, 2016 - 2028 (USD Million)
5.5. Physical
5.5.1. Global Gene Delivery Technologies Market, by Physical, by Region, 2016 - 2028 (USD Million)
6. Global Gene Delivery Technologies Market, by Application
6.1. Key Findings
6.2. Introduction
6.2.1. Global Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
6.3. Gene Therapy
6.3.1. Global Gene Delivery Technologies Market, by Gene Therapy, By Region, 2016 - 2028 (USD Million)
6.4. Cell Therapy
6.4.1. Global Gene Delivery Technologies Market, by Cell Therapy, by Region, 2016 - 2028 (USD Million)
6.5. Vaccines
6.5.1. Global Gene Delivery Technologies Market, by Vaccines, by Region, 2016 - 2028 (USD Million)
6.6. Research
6.6.1. Global Gene Delivery Technologies Market, by Research, by Region, 2016 - 2028 (USD Million)
7. Gene Delivery Technologies Market Assessment by Method
7.1. Key Findings
7.2. Introduction
7.2.1. Global Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
7.3. Ex vivo
7.3.1. Global Gene Delivery Technologies Market, by Ex vivo, by Region, 2016 - 2028 (USD Million)
7.4. In vivo
7.4.1. Global Gene Delivery Technologies Market, by In vivo, by Region, 2016 - 2028 (USD Million)
7.5. In vitro
7.5.1. Global Gene Delivery Technologies Market, by In vitro, by Region, 2016 - 2028 (USD Million)
8. Gene Delivery Technologies Market Assessment by Geography
8.1. Key findings
8.2. Introduction
8.2.1. Gene Delivery Technologies Market Assessment, By Geography, 2016 - 2028 (USD Million)
8.3. Gene Delivery Technologies Market - North America
8.3.1. North America: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
8.3.2. North America: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
8.3.3. North America: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
8.3.4. Gene Delivery Technologies Market - U. S.
8.3.4.1. U. S.: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
8.3.4.2. U. S.: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
8.3.4.3. U. S.: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
8.3.5. Gene Delivery Technologies Market - Canada
8.3.5.1. Canada: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
8.3.5.2. Canada.: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
8.3.5.3. Canada: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
8.4. Gene Delivery Technologies Market - Europe
8.4.1. Europe: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
8.4.2. Europe.: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
8.4.3. Europe: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
8.4.4. Gene Delivery Technologies Market - UK
8.4.4.1. UK: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
8.4.4.2. UK.: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
8.4.4.3. UK: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
8.4.5. Gene Delivery Technologies Market - France
8.4.5.1. France: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
8.4.5.2. France.: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
8.4.5.3. France: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
8.4.6. Gene Delivery Technologies Market - Germany
8.4.6.1. Germany: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
8.4.6.2. Germany.: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
8.4.6.3. Germany: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
8.4.7. Gene Delivery Technologies Market - Italy
8.4.7.1. Italy: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
8.4.7.2. Italy.: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
8.4.7.3. Italy: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
8.4.8. Gene Delivery Technologies Market - Spain
8.4.8.1. Spain: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
8.4.8.2. Spain.: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
8.4.8.3. Spain: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
8.4.9. Gene Delivery Technologies Market - Netherlands
8.4.9.1. Netherlands: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
8.4.9.2. Netherlands.: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
8.4.9.3. Netherlands: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
8.4.10. Gene Delivery Technologies Market - Austria
8.4.10.1. Austria: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
8.4.10.2. Austria.: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
8.4.10.3. Austria: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
8.5. Gene Delivery Technologies Market - Asia-Pacific
8.5.1. Asia Pacific: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
8.5.2. Asia Pacific.: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
8.5.3. Asia Pacific: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
8.5.4. Gene Delivery Technologies Market - China
8.5.4.1. China: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
8.5.4.2. China.: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
8.5.4.3. China: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
8.5.5. Gene Delivery Technologies Market - India
8.5.5.1. India: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
8.5.5.2. India.: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
8.5.5.3. India: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
8.5.6. Gene Delivery Technologies Market - Malaysia
8.5.6.1. Malaysia: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
8.5.6.2. Malaysia.: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
8.5.6.3. Malaysia: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
8.5.7. Gene Delivery Technologies Market - Japan
8.5.7.1. Japan: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
8.5.7.2. Japan.: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
8.5.7.3. Japan: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
8.5.8. Gene Delivery Technologies Market - Indonesia
8.5.8.1. Indonesia: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
8.5.8.2. Indonesia.: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
8.5.8.3. Indonesia: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
8.5.9. Gene Delivery Technologies Market - South Korea
8.5.9.1. South Korea: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
8.5.9.2. South Korea.: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
8.5.9.3. South Korea: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
8.6. Gene Delivery Technologies Market - Middle East & Africa
8.6.1. Middle East & Africa: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
8.6.2. Middle East & Africa.: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
8.6.3. Middle East & Africa: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
8.6.4. Gene Delivery Technologies Market - Saudi Arabia
8.6.4.1. Saudi Arabia: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
8.6.4.2. Saudi Arabia.: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
8.6.4.3. Saudi Arabia: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
8.6.5. Gene Delivery Technologies Market - UAE
8.6.5.1. UAE: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
8.6.5.2. UAE.: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
8.6.5.3. UAE: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
8.6.6. Gene Delivery Technologies Market - Israel
8.6.6.1. Israel: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
8.6.6.2. Israel.: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
8.6.6.3. Israel: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
8.6.7. Gene Delivery Technologies Market - South Africa
8.6.7.1. South Africa: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
8.6.7.2. South Africa.: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
8.6.7.3. South Africa: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
8.7. Gene Delivery Technologies Market - Latin America
8.7.1. Latin America: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
8.7.2. Latin America.: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
8.7.3. Latin America: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
8.7.4. Gene Delivery Technologies Market - Mexico
8.7.4.1. Mexico: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
8.7.4.2. Mexico.: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
8.7.4.3. Mexico: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
8.7.5. Gene Delivery Technologies Market - Brazil
8.7.5.1. Brazil: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
8.7.5.2. Brazil.: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
8.7.5.3. Brazil: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)'
8.7.6. Gene Delivery Technologies Market - Argentina
8.7.6.1. Argentina: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
8.7.6.2. Argentina.: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
8.7.6.3. Argentina: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
9. Competitive Landscape
9.1. Expansion and Acquisition Analysis
9.1.1. Expansion
9.1.2. Acquisition
9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
10.1. Thermo Fisher Scientific, Inc.
10.1.1. Company Overview
10.1.2. Financial Performance
10.1.3. Product & Services Benchmarking
10.1.4. Recent Development
10.2. Horizon Discovery Group Co.
10.2.1. Company Overview
10.2.2. Financial Performance
10.2.3. Product & Services Benchmarking
10.2.4. Recent Development
10.3. OriGene Technologies, Inc.
10.3.1. Company Overview
10.3.2. Financial Performance
10.3.3. Product & Services Benchmarking
10.3.4. Recent Development
10.4. Oxford Biomedica
10.4.1. Company Overview
10.4.2. Financial Performance
10.4.3. Product & Services Benchmarking
10.4.4. Recent Development
10.5. SignaGen Laboratories
10.5.1. Company Overview
10.5.2. Financial Performance
10.5.3. Product & Services Benchmarking
10.5.4. Recent Development
10.6. Takara Bio Inc.
10.6.1. Company Overview
10.6.2. Financial Performance
10.6.3. Product & Services Benchmarking
10.6.4. Recent Development
10.7. System Biosciences llc
10.7.1. Company Overview
10.7.2. Financial Performance
10.7.3. Product & Services Benchmarking
10.7.4. Recent Development
10.8. Promega Corporation
10.8.1. Company Overview
10.8.2. Financial Performance
10.8.3. Product & Services Benchmarking
10.8.4. Recent Development
10.9. F. Hoffmann - La Roche AG
10.9.1. Company Overview
10.9.2. Financial Performance
10.9.3. Product & Services Benchmarking
10.9.4. Recent Development
10.10. QIAGEN
10.10.1. Company Overview
10.10.2. Financial Performance
10.10.3. Product & Services Benchmarking
10.10.4. Recent Development
10.11. Vectalys
10.11.1. Company Overview
10.11.2. Financial Performance
10.11.3. Product & Services Benchmarking
10.11.4. Recent Development
10.12. Bio - Rad Laboratories, Inc.
10.12.1. Company Overview
10.12.2. Financial Performance
10.12.3. Product & Services Benchmarking
10.12.4. Recent Development
10.13. Catalent Inc.
10.13.1. Company Overview
10.13.2. Financial Performance
10.13.3. Product & Services Benchmarking
10.13.4. Recent Development
10.14. Agilent Technologies
10.14.1. Company Overview
10.14.2. Financial Performance
10.14.3. Product & Services Benchmarking
10.14.4. Recent Development
10.15. Sirion - Biotech GmbH
10.15.1. Company Overview
10.15.2. Financial Performance
10.15.3. Product & Services Benchmarking
10.15.4. Recent Development
List of Tables
Table 1. Global Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
Table 2. Global Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
Table 3. Global Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
Table 4. Gene Delivery Technologies Market Assessment, By Geography, 2016 - 2028 (USD Million)
Table 5. North America: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
Table 6. North America: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
Table 7. North America: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
Table 8. U.S.: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
Table 9. U.S.: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
Table 10. U.S.: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
Table 11. Canada: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
Table 12. Canada: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
Table 13. Canada: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
Table 14. Europe: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
Table 15. Europe: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
Table 16. Europe: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
Table 17. UK: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
Table 18. UK: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
Table 19. UK: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
Table 20. France: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
Table 21. France: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
Table 22. France: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
Table 23. Germany: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
Table 24. Germany: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
Table 25. Germany: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
Table 26. Italy: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
Table 27. Italy: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
Table 28. Italy: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
Table 29. Spain: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
Table 30. Spain: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
Table 31. Spain: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
Table 32. Netherlands: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
Table 33. Netherlands: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
Table 34. Netherlands: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
Table 35. Austria: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
Table 36. Austria: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
Table 37. Austria: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
Table 38. Asia Pacific: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
Table 39. Asia Pacific: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
Table 40. Asia Pacific: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
Table 41. China: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
Table 42. China: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
Table 43. China: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
Table 44. India: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
Table 45. India: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
Table 46. India: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
Table 47. Malaysia: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
Table 48. Malaysia: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
Table 49. Malaysia: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
Table 50. Japan: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
Table 51. Japan: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
Table 52. Japan: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
Table 53. Indonesia: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
Table 54. Indonesia: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
Table 55. Indonesia: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
Table 56. South Korea: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
Table 57. South Korea: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
Table 58. South Korea: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
Table 59. Middle East & Africa: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
Table 60. Middle East & Africa: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
Table 61. Middle East & Africa: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
Table 62. Saudi Arabia: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
Table 63. Saudi Arabia: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
Table 64. Saudi Arabia: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
Table 65. UAE: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
Table 66. UAE: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
Table 67. UAE: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
Table 68. Israel: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
Table 69. Israel: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
Table 70. Israel: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
Table 71. South Africa: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
Table 72. South Africa: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
Table 73. South Africa: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
Table 74. Latin America: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
Table 75. Latin America: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
Table 76. Latin America: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
Table 77. Mexico: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
Table 78. Mexico: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
Table 79. Mexico: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
Table 80. Brazil: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
Table 81. Brazil: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
Table 82. Brazil: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
Table 83. Argentina: Gene Delivery Technologies Market, By Mode, 2016 - 2028 (USD Million)
Table 84. Argentina: Gene Delivery Technologies Market, By Application, 2016 - 2028 (USD Million)
Table 85. Argentina: Gene Delivery Technologies Market, By Method, 2016 - 2028 (USD Million)
List of Figures
Figure 1. Market Highlights (2020, Revenue)
Figure 2. Integrated Ecosystem
Figure 3. Research Methodology: Top Down & Bottom Up Approach
Figure 4. Market by Geography
Figure 6. Porter’s Five Forces
Figure 7. Market by Mode
Figure 8. Global Gene Delivery Technologies Market, By Mode, 2020 & 2028 (USD Million)
Figure 9. Market by Application
Figure 10. Global Gene Delivery Technologies Market, By Application, 2020 & 2028 (USD Million)
Figure 11. Market by Method
Figure 12. Global Gene Delivery Technologies Market, By Method, 2020 & 2028 (USD Million)
Figure 13. Gene Delivery Technologies Market Assessment, By Geography, 2016 - 2028 (USD Million)
Figure 14. Strategic Analysis - Gene Delivery Technologies Market

Companies Mentioned

  • Horizon Discovery Group Co.
  • QIAGEN
  • Oxford Biomedica
  • SignaGen Laboratories
  • Hoffmann-La Roche AG
  • Vectalys
  • Sirion-Biotech GmbH
  • Takara Bio Inc.
  • Bio-Rad Laboratories Inc.
  • Thermo Fisher Scientific Inc.
  • OriGene Technologies Inc.
  • System Biosciences
  • Promega Corporation
  • Catalent Inc.